EMEACR (Europe, Middle East & Africa Clinical Research) 在哪里?
EMEACR (Europe, Middle East & Africa Clinical Research) 的总部位于 dubiotech, dubai, dubai, united arab emirates
EMEACR (Europe, Middle East & Africa Clinical Research) 的电话号码是多少?
EMEACR (Europe, Middle East & Africa Clinical Research) 的电话号码是 +971 55 566 3870
EMEACR (Europe, Middle East & Africa Clinical Research) 的官方网站是什么?
EMEACR (Europe, Middle East & Africa Clinical Research) 的公司官方网站是 http://www.emeacr.org
EMEACR (Europe, Middle East & Africa Clinical Research) 是做什么的?
EMEACR (Europe, Middle East & Africa Clinical Research) 的业务有哪些?
clinical operation,regulatory submissions,sites selection,feasibility,monitoring,project management,data management,stat,medical writing,pharmacovigilance,training,quality assurance,staff outsourcing,beba studies,emerging markets
EMEACR (Europe, Middle East & Africa Clinical Research) 的年收入是多少?
EMEACR (Europe, Middle East & Africa Clinical Research) 的收入是 0美元
EMEACR (Europe, Middle East & Africa Clinical Research) 有多少员工?
EMEACR (Europe, Middle East & Africa Clinical Research) 有 2 名员工
EMEACR (Europe, Middle East & Africa Clinical Research) 属于哪个行业?
EMEACR (Europe, Middle East & Africa Clinical Research) 从事以下行业: pharmaceuticals
EMEACR (Europe, Middle East & Africa Clinical Research) 使用什么技术?
EMEACR (Europe, Middle East & Africa Clinical Research) 使用的一些流行技术包括:
如何联系 EMEACR (Europe, Middle East & Africa Clinical Research)?
EMEACR (Europe, Middle East & Africa Clinical Research) 联系信息:
电话号码:+971 55 566 3870,
网站:http://www.emeacr.org,
邮箱:-
EMEACR (Europe, Middle East & Africa Clinical Research) 的社交媒体链接是什么?
EMEACR (Europe, Middle East & Africa Clinical Research) 领英:http://www.linkedin.com/company/emeacr-europe-middle-east-&-africa-clinical-research-,fackbook:,twitte:https://twitter.com/EMEACR
EMEACR (Europe, Middle East & Africa Clinical Research) 是一家上市公司吗?
不是
EMEACR (Europe, Middle East & Africa Clinical Research) 的最后一轮融资是什么时候?
暂无最近投资信息
谁投资 EMEACR (Europe, Middle East & Africa Clinical Research)?
EMEACR (Europe, Middle East & Africa Clinical Research) 有 0 家投资者,包括 。